ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Erasmus MC at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Erasmus MC takes part in 18 sessions at ESMO 2026 in Madrid. Its program spans treatment and care across several cancers, with particular attention to gastrointestinal and thoracic cancers. Specific topics include whether some patients with oesophageal cancer can avoid surgery after chemoradiotherapy and ways to detect lung nodules using artificial intelligence.
| Organization | ESMO 2026 Attendance |
|---|---|
Erasmus MC Rotterdam, Netherlands | |
University medical centre in Rotterdam, Netherlands, with a dedicated cancer institute. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Life after “cure”: Long-term challenges and needs of metastatic melanoma survivors after discharge from oncology follow-up following durable response to immune checkpoint inhibitors Melanoma & skin cancersNursing & supportive care Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Abstract Fri Oct 23 13:40–13:50 Chair Sat Oct 24 08:30–09:15 Sequencing systemic therapies for advanced urothelial cancer Genitourinary cancers Poster Sat Oct 24 12:00–12:45 Health-related quality of life in the prospective Safe Stop Trial: Early discontinuation of anti-PD1 therapy upon achieving a complete or partial response in patients with metastatic melanoma Melanoma & skin cancersNursing & supportive care Chair Sat Oct 24 14:45–16:15 Updates on rare thoracic tumours Lung & thoracic cancers Talk Sat Oct 24 15:25–15:45 Neuroendocrine tumours beyond SCLC Lung & thoracic cancers Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Plasma ctDNA methylation haplotype profiling as a predictive biomarker for FOLFIRINOX response in pancreatic ductal adenocarcinoma Gastrointestinal cancersBiomarkers & precision oncology Talk Sun Oct 25 15:25–15:45 Abstract Mon Oct 26 10:25–10:35 Invited Discussant 3837RO and 3816RO Lung & thoracic cancers Talk Mon Oct 26 10:40–11:00 Dealing with oligoprogression Gynaecological cancers Chair Mon Oct 26 14:45–16:15 Proffered paper: Non-metastatic NSCLC and other thoracic malignancies Lung & thoracic cancers Talk Mon Oct 26 16:30–16:50 The pathologist guidance in clinical decision-making in early stage NSCLC Lung & thoracic cancers Satellite Mon Oct 26 19:30–19:45 Real-world clinical experience with I-O in ES-SCLC Lung & thoracic cancers |
Find decision makers at Erasmus MC
Tell us what you sell and we’ll find the people at Erasmus MC most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction